GL - NYSE

Globe Life Inc.

GL·NYSE

$151.20

+0.099%

Financial ServicesInsurance - Life

Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole life, term life, and other life insurance products; Medicare supplement and supplemental health insurance, such as critical illness and accident plans; and single-premium and flexible-premium deferred annuities. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was incorporated in 1979 and is headquartered in McKinney, Texas.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$11.74B

EPS14.3000

P/E Ratio10.57

Earnings Date07/22/2026

30.81B

Assets

3Y+19.0%

5Y+6.0%

10Y+44.0%

24.84B

Total Liabilities

3Y+13.0%

5Y+23.0%

10Y+47.0%

5.97B

Total Equity

13%

3Y+51.0%

5Y-32.0%

10Y+31.0%

Globe Life Inc. Funding & Solvency Profile

GL · NYSE

Current Assets

Cash & Cash Equivalents144.70M

Net Receivables1.04B

Inventory0.00

Other Current Assets0.00

Total Current Assets19 B

Non-Current Assets

Property, Plant & Equipment370.00M

Goodwill & Intangible Assets7.49B

Long-Term Investments2.57B

Other Non-Current Assets1.30B

Total Non-Current Assets4 B

Total Assets

30.81B

Financial Health Analysis

Current Ratio

9.66x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

4.16x

High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.

Working Capital

17 B

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

62% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Financial Health Insight

Mixed signals: Strong short-term liquidity provides comfort, but high overall leverage requires careful monitoring of debt servicing capabilities and refinancing risk.

Globe Life Inc. Balance Sheet

GL • NYSE

Globe Life Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	144.7M	165.3M	103.2M	92.6M	92.2M	94.8M	75.9M	121M	118.6M	76.2M	61.4M	66M	36.9M	61.7M	84.1M	365.7M	231.9M	46.4M	20.1M	16.7M
Short-Term Investments	17.9B	17.2B	18B	16.6B	21.4B	21.3B	18.9B	16.4B	17.1B	15.3B	13.8B	14.5B	13B	13.6B	21.2M	216.7M	357.6M	131M	111.2M	156.7M
Cash & Short-Term Investments	18B	17.4B	18.1B	16.7B	21.5B	21.4B	19B	16.5B	17.2B	15.4B	13.9B	14.6B	13B	13.7B	105.4M	582.4M	589.5M	177.4M	131.3M	173.4M
Net Receivables	1B	961.7M	900.6M	848.8M	738.8M	474.2M	441.7M	415.2M	391.8M	384.5M	344.6M	327.9M	331.1M	383.7M	253.5M	230.3M	197.2M	151.7M	96.8M	78.8M
Accounts Receivables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	253.5M	230.3M	197.2M	151.7M	96.8M	78.8M
Other Receivables	1B	961.7M	900.6M	848.8M	738.8M	474.2M	441.7M	415.2M	391.8M	384.5M	344.6M	327.9M	331.1M	383.7M	0.0	0.0	0.0	0.0	0.0	0.0
Other Current Assets	0.0	0.0	0.0	0.0	0.0	-21.9B	-19.5B	342.2M	246.3M	177.4M	186.3M	932.6M	132.9M	74.4M	12.1B	10.8B	10B	8.1B	9.6B	0.0
Total Current Assets	19.1B	18.4B	19B	17.6B	22.2B	0.0	0.0	17.2B	17.9B	16B	14.4B	15.1B	13.5B	14.2B	12.4B	11.6B	10.7B	8.4B	9.8B	16.7M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	370M	285M	240M	212M	205M	186M	161M	135M	108M	97M	83M	54M	51M	46M	-1.5B	-1.2B	-966.4M	-419.2M	-966M	-1B
Goodwill	490.4M	490.4M	481.8M	481.8M	481.8M	441.6M	441.6M	441.6M	441.6M	441.6M	441.6M	441.6M	441.6M	441.6M	396.9M	396.9M	423.5M	423.5M	423.5M	378.4M
Intangible Assets	7B	6.5B	6B	5.5B	4.9B	0.0	0.0	4.1B	4B	3.8B	0.0	3.5B	3.3B	3.2B	0.0	0.0	0.0	0.0	0.0	0.0
Goodwill & Intangible Assets	7.5B	7B	6.5B	6B	5.4B	441.6M	441.6M	4.6B	4.4B	4.2B	441.6M	3.9B	3.8B	3.6B	396.9M	396.9M	423.5M	423.5M	423.5M	378.4M
Long-Term Investments	2.6B	2.3B	1.8B	1.6B	1.4B	21.3B	18.9B	16.4B	17.1B	15.3B	13.8B	14.5B	13B	13.7B	11.9B	10.8B	10.1B	8B	9.4B	9.3B
Tax Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1B	1.3B	1.7B	1.5B	1.8B	1.3B	1.6B	1.5B	1.2B	966.4M	419.2M	966M	1B
Other Non-Current Assets	1.3B	1.1B	592.4M	607.6M	577.6M	-21.9B	-19.5B	-12.1B	-13.3B	-12.1B	-10.3B	-11.7B	-10B	-11.1B	-7.8B	-6.8B	-10.1B	-8B	-9.4B	-9.3B
Total Non-Current Assets	11.7B	10.7B	9.1B	8.4B	7.6B	0.0	0.0	5.9B	5.6B	5.5B	5.4B	5.1B	4.7B	4.6B	4.5B	4.4B	423.5M	423.5M	423.5M	378.4M
Other Assets	0.0	0.0	0.0	0.0	0.0	29B	26B	0.0	0.0	0.0	0.0	44.1M	0.0	0.0	192.3M	183.9M	4.9B	4.7B	5B	14.6B
Total Assets	30.8B	29.1B	28.1B	26B	29.8B	29B	26B	23.1B	23.5B	21.4B	19.9B	20.2B	18.2B	18.8B	17.2B	16.2B	16B	13.5B	15.2B	15B
LIABILITIES
CURRENT LIABILITIES
Total Payables	1.4B	1.3B	1B	944M	2.2B	2.2B	1.8B	1B	1.3B	1.7B	1.5B	1.8B	1.3B	1.8B	1.5B	346M	964.7M	419.2M	966M	1B
Accounts Payable	540.8M	532.8M	514.9M	509.4M	412.9M	399.5M	365.4M	0.0	0.0	0.0	0.0	0.0	0.0	228.5M	222.3M	221.6M	0.0	0.0	0.0	0.0
Other Payables	859.6M	731.3M	494.6M	434.6M	1.8B	1.8B	1.5B	1B	1.3B	1.7B	1.5B	1.8B	1.3B	1.6B	1.3B	124.4M	197.2M	151.7M	96.8M	78.8M
Short Term Debt	304.7M	415.4M	486.1M	449.1M	479.6M	254.9M	298.7M	307.8M	328.1M	264.5M	490.1M	238.4M	229.1M	319M	224.8M	198.9M	233.3M	403.7M	202.1M	169.7M
Tax Payables	0.0	731.3M	494.6M	434.6M	1.8B	1.8B	1.5B	1B	1.3B	1.7B	1.5B	1.8B	1.3B	1.6B	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Revenue	270.7M	257.6M	254.6M	253.4M	65.5M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Current Liabilities	0.0	0.0	0.0	0.0	0.0	-2.5B	-2.1B	-1.4B	-1.6B	-2B	-1.9B	-2B	-1.5B	0.0	-1.8B	-544.9M	-1.2B	-822.9M	-1.2B	-1.2B
Total Current Liabilities	2B	1.9B	1.8B	1.6B	2.7B	0.0	0.0	16.3B	16.1B	15.7B	15.1B	14.6B	13.4B	13.4B	12.1B	11.4B	11.8B	10.8B	11.3B	10.9B
NON-CURRENT LIABILITIES
Long Term Debt	2.3B	2.3B	1.6B	1.6B	1.5B	1.7B	1.3B	1.4B	1.1B	1.1B	743.7M	992.1M	990.9M	989.7M	915M	789.6M	920.5M	623.5M	722.4M	722M
Deferred Tax Liabilities (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	966M	1B
Other Non-Current Liabilities	20.5B	19.5B	20.2B	18.8B	16.9B	-1.7B	-1.3B	16.3B	14.1B	15.7B	12.8B	12.3B	11.7B	11.3B	-915M	-789.6M	-920.5M	-623.5M	-722.4M	-722M
Total Non-Current Liabilities	22.9B	21.8B	21.8B	20.4B	18.4B	0.0	0.0	1.4B	1.1B	1.1B	743.7M	992.1M	991M	990M	791M	790M	796M	499M	598M	598M
Other Liabilities	0.0	0.0	0.0	0.0	0.0	20.3B	18.7B	0.0	0.0	0.0	0.0	-57.5M	402K	124K	483K	-479K	-132K	143K	-199K	162K
Total Liabilities	24.8B	23.8B	23.6B	22B	21.1B	20.3B	18.7B	17.7B	17.2B	16.9B	15.8B	15.5B	14.4B	14.4B	12.9B	12.1B	12.6B	11.3B	11.9B	11.5B
SHAREHOLDERS' EQUITY
Treasury Stock	-1.4B	-1.3B	-854.3M	-789.5M	-846.7M	-772.9M	-750.6M	-763.4M	-631.8M	-519.2M	-403.3M	-268.7M	-543.4M	-512.4M	-492.6M	-32.6M	-36.1M	-67.6M	-173.7M	-100.4M
Common Stock	92.2M	97.2M	102.2M	105.2M	109.2M	113.2M	117.2M	121.2M	124.2M	127.2M	130.2M	134.2M	100.8M	105.8M	112.3M	79.9M	83.9M	85.9M	94.9M	99.9M
Additional Paid-In Capital	536.4M	527.8M	532.5M	529.7M	520.6M	527.4M	531.6M	524.4M	508.5M	490.4M	482.3M	457.6M	462.1M	439.8M	425.3M	432.6M	441.4M	446.1M	481.2M	492.3M
Retained Earnings	8.5B	8B	7.5B	6.9B	6.2B	5.9B	5.6B	5.2B	4.8B	3.9B	3.6B	3.4B	3.5B	3.4B	3.6B	3.5B	3.2B	2.9B	3B	2.8B
Accumulated Other Comprehensive Income/Loss	-1.8B	-2B	-2.8B	-2.8B	2.7B	3B	1.8B	319.5M	1.4B	577.6M	231.9M	997.5M	211M	925.3M	549.4M	23M	-319.2M	-1.2B	-80.9M	140.1M
Total Stockholders' Equity	6B	5.3B	4.5B	3.9B	8.6B	8.8B	7.3B	5.4B	6.2B	4.6B	4.1B	4.7B	3.8B	4.4B	4.2B	4B	3.4B	2.2B	3.3B	3.5B
Total Equity	6B	5.3B	4.5B	3.9B	8.6B	8.8B	7.3B	5.4B	6.2B	4.6B	4.1B	4.7B	3.8B	4.4B	4.2B	4B	3.4B	2.2B	3.3B	3.5B
SUMMARY
Total Liabilities & Equity	30.8B	29.1B	28.1B	26B	29.8B	29B	26B	23.1B	23.5B	21.4B	19.9B	20.2B	18.2B	18.8B	17.2B	16.2B	16B	13.5B	15.2B	15B
Total Investments	20.5B	19.6B	19.7B	18.2B	22.8B	22.5B	19.8B	17.1B	17.7B	15.9B	27.6B	15B	13.4B	14.1B	11.9B	11B	10.4B	8.1B	9.5B	9.7B
Total Debt	2.6B	2.7B	2.1B	2.1B	2B	1.9B	1.6B	1.7B	1.5B	1.4B	1.2B	1.2B	1.2B	1.3B	1B	988.5M	1.2B	1B	924.5M	891.7M
Net Debt	2.5B	2.6B	2B	2B	1.9B	1.8B	1.6B	1.5B	1.3B	1.3B	1.2B	1.2B	1.2B	1.2B	931.3M	622.8M	921.9M	980.8M	904.4M	875M
Shares Outstanding	79,605,800	79,605,800	79,605,800	79,605,800	79,605,800	79,605,800	79,605,800	79,605,800	79,605,800	79,605,800	79,605,800	79,605,800	79,605,800	79,605,800	79,605,800	79,605,800	79,605,800	79,605,800	79,605,800	79,605,800

SEC Filings

GL - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
10-Q 10-Q 2026 Q1 Q1	May 07, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 04, 2026	May 04, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 22, 2026	April 22, 2026	2026	View Filing
DEF 14A DEF 14A 2025 N/A	March 19, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 27, 2026	February 27, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 25, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 04, 2026	February 04, 2026	2026	View Filing
8-K 8-K 2025 N/A	November 06, 2025	November 06, 2025	2025	View Filing
10-Q 10-Q 2025 Q3 Q3	November 05, 2025	September 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	October 22, 2025	October 22, 2025	2025	View Filing

Showing 1 to 10 of 476 filings

Related Guides

Blog Categories

Continue your GL research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.